Physician profile
Brian G Dickson
NPI 1215908710
$3,484.48
in general payments reported to CMS, 2019-2025
25 companies · $343 in 2025
The $343 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $420 · 2020: $179 · 2021: $1,676 · 2022: $519 · 2023: $192 · 2024: $155 · 2025: $343.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $690.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $690.41 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Health Care Systems INC. | $1,386.80 | 2021 | |
| Zimmer Biomet Holdings, INC. | $539.80 | 2020-2022 | |
| Baxter Healthcare | $330.04 | 2024-2025 | Perclot, Tisseel, Recothrom |
| Smith+Nephew, INC. | $305.82 | 2019 | |
| Amgen INC. | $131.65 | 2019-2021 | |
| Medical Device Business Services, INC. | $101.38 | 2021 | |
| Djo, LLC | $80.70 | 2021 | |
| Stryker Corporation | $73.32 | 2023-2024 | Ortholoc 3di, T2, Mako |
| Abiomed | $69.89 | 2023-2024 | Impella |
| Organogenesis INC. | $69.56 | 2021-2025 | Puraply Wound Matrix |
| Bioventus LLC | $58.54 | 2020-2024 | Exogen Ultrasound Bone Healing System |
| Orthofix Medical, INC. | $44.81 | 2019-2023 | Physio-Stim |
| Treace Medical Concepts, INC. | $43.54 | 2022 | |
| Radius Health, INC. | $40.07 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $35.29 | 2023 | Iovera |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cvrx, INC. | $29.62 | 2023 | Barostim Neo System |
| Vertex Pharmaceuticals Incorporated | $23.08 | 2025 | |
| Averitas Pharma INC. | $21.98 | 2024 | Qutenza |
| Davol INC. | $18.19 | 2025 | Arista |
| Horizon Therapeutics Plc | $15.33 | 2019 | |
| Polynovo North America LLC | $14.07 | 2025 | Novosorb Btm |
| Depuy Synthes Sales INC. | $14.06 | 2020 | |
| Fidia Pharma USA INC. | $12.68 | 2019 | |
| Ferring Pharmaceuticals INC. | $12.28 | 2020 | |
| Sanofi-Aventis U.S. LLC | $11.98 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Dickson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.